Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""DIABETIC nephropathies"" wg kryterium: Temat


Tytuł:
A late eating midpoint is associated with increased risk of diabetic kidney disease: a cross-sectional study based on NHANES 2013-2020.
Autorzy:
Lu CF; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Cang XM; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Liu WS; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Wang LH; Department of Nursing, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Huang HY; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China.
Wang XQ; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China. .
Zhao LH; Department of Nursing, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China. .
Xu F; Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, No. 666 Shengli Road, Nantong, 226001, China. .
Pokaż więcej
Źródło:
Nutrition journal [Nutr J] 2024 Mar 23; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/epidemiology
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/metabolism
Diabetes Mellitus, Type 2*/complications
Humans ; Nutrition Surveys ; Cross-Sectional Studies ; Kidney ; Glomerular Filtration Rate
Czasopismo naukowe
Tytuł:
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.
Autorzy:
Wang N; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhang C; Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/etiology
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin Receptor Antagonists/pharmacology ; Kidney/pathology
Czasopismo naukowe
Tytuł:
Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis.
Autorzy:
Zheng R; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xu Q; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhong Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhu R; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 300-314. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/prevention & control
Diabetes Mellitus, Type 2*
MicroRNAs*
Cordyceps*
Animals ; Mice ; Reactive Oxygen Species ; Antibodies ; Inflammation ; Luciferases ; Glucose
SCR Organism:
Cordyceps cicadae
Czasopismo naukowe
Tytuł:
Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease.
Autorzy:
Yang L; Department of Nephrology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Shen Y; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Li W; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.; Center of Community-Based Health Research, Fudan University, Shanghai, China.; Jiangchuan Community Health Service Center, Shanghai, China.
Zha B; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Xu W; Department of Nephrology, Zhejiang Kaihua County Hospital of Chinese Medicine, Zhejiang, China.
Ding H; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Journal of diabetes [J Diabetes] 2024 Mar; Vol. 16 (3), pp. e13508. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/etiology
Diabetes Mellitus, Type 2*
Humans ; Myoglobin ; Glomerular Filtration Rate ; Kidney
Czasopismo naukowe
Tytuł:
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Autorzy:
Gamez M; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom. .
Elhegni HE; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Fawaz S; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Ho KH; Department of Computer Science, Merchant Venturers Building, University of Bristol, Woodland Road, Bristol, BS8 1UB, United Kingdom.
Campbell NW; Department of Computer Science, Merchant Venturers Building, University of Bristol, Woodland Road, Bristol, BS8 1UB, United Kingdom.
Copland DA; Academic Unit of Ophthalmology, Translational Health Sciences, Bristol Medical School, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.
Onions KL; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Butler MJ; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Wasson EJ; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Crompton M; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Ramnath RD; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Qiu Y; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Yamaguchi Y; Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA, 92037, USA.
Arkill KP; School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2UH, United Kingdom.
Bates DO; School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2UH, United Kingdom.
Turnbull JE; Centre for Glycoscience, School of Life Sciences, Keele University, Staffordshire, ST5 5BG, United Kingdom.
Zubkova OV; Ferrier Research Institute, Victoria University of Wellington, 69 Gracefield Rd, Lower Hutt, 5046, New Zealand.
Welsh GI; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Atan D; Academic Unit of Ophthalmology, Translational Health Sciences, Bristol Medical School, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, United Kingdom.; Bristol Eye Hospital, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, BS1 2LX, United Kingdom.
Satchell SC; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Foster RR; Bristol Renal, Bristol Medical School, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, United Kingdom.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 01; Vol. 23 (1), pp. 50. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/prevention & control
Diabetic Angiopathies*/etiology
Diabetic Angiopathies*/prevention & control
Diabetic Angiopathies*/metabolism
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Glucuronidase*
Animals ; Mice ; Glycocalyx/metabolism ; Heparitin Sulfate/metabolism ; Heparitin Sulfate/pharmacology ; Albumins/pharmacology
Czasopismo naukowe
Tytuł:
Prevalence of diabetic kidney disease and the associated factors among patients with type 2 diabetes in a multi-ethnic Asian country.
Autorzy:
Wan KS; Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Shah Alam, Selangor, Malaysia. .; Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, 50603, Federal Territory of Kuala Lumpur, Malaysia. .
Hairi NN; Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, 50603, Federal Territory of Kuala Lumpur, Malaysia.; Faculty of Public Health, Universitas Airlangga, Surabaya, 60115, East Java, Indonesia.
Mustapha F; Disease Control Division, Ministry of Health Malaysia, Federal Government Administration Centre, 62590, Putrajaya, Malaysia.; Perak State Health Department, Ministry of Health Malaysia, 30000, Ipoh, Perak, Malaysia.
Mohd Yusoff MF; Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Shah Alam, Selangor, Malaysia.
Mat Rifin H; Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Shah Alam, Selangor, Malaysia.
Ismail M; Family Health Development Division, Ministry of Health Malaysia, Federal Government Administration Centre, 62590, Putrajaya, Malaysia.
Moy FM; Centre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, 50603, Federal Territory of Kuala Lumpur, Malaysia.
Ahmad NA; Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170, Shah Alam, Selangor, Malaysia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 25; Vol. 14 (1), pp. 7074. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/etiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Humans ; Male ; Female ; Middle Aged ; Prevalence ; Cross-Sectional Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.
Autorzy:
Schaefer F; Pediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany. .
Montini G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Department of Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Kang HG; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Walle JV; Department of Pediatric Nephrology, Ghent University Hospital, Erknet Center, C4C, Ghent, Belgium.
Zaritsky J; Department of Nephrology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Schreuder MF; Department of Pediatric Nephrology, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.
Litwin M; Department of Nephrology and Arterial Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
Scalise A; Bayer Hispania, S.L, Sant Joan Despi, Barcelona, Spain.
Scott H; Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
Potts J; Bayer U.S Pharmaceuticals, Whippany, NJ, USA.
Iveli P; Bayer AG, Wuppertal, Germany.
Breitenstein S; Bayer AG, Wuppertal, Germany.
Warady BA; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.; Children's Mercy Kansas City, Kansas City, MO, USA.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 21; Vol. 25 (1), pp. 203. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Diabetic Nephropathies*/drug therapy
Naphthyridines*
Adult ; Humans ; Child ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Proteinuria/drug therapy ; Proteinuria/chemically induced ; Mineralocorticoid Receptor Antagonists/adverse effects
Czasopismo naukowe
Tytuł:
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus.
Autorzy:
Nugnes M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Baldassarre M; Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Ribichini D; Endocrinology and Diabetes Prevention and Care Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Tedesco D; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Institute for Organic Synthesis and Photoreactivity, National Research Council, 40129 Bologna, Italy.
Capelli I; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Vetrano D; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Marchignoli F; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Brodosi L; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pompili E; Unit of Semeiotics, Liver and Alcohol-Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Petroni ML; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
La Manna G; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Marchesini G; Unit of Clinical Nutrition, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Naldi M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.; Centre for Applied Biomedical Research (CRBA), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Bartolini M; Department of Pharmacy and Biotechnology, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 09; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/complications
Humans ; Glomerular Filtration Rate ; Sensitivity and Specificity ; Kidney
Czasopismo naukowe
Tytuł:
Application of hospital-community-home linkage management model in patients with type 2 diabetic nephropathy.
Autorzy:
Xu HM; Department of Education, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Zhai YP; Department of Internal Medicine, Shanxi Bethune Hospital, Xiaodian District, 99 Longcheng Street, Taiyuan, 030032, Shanxi, China. zhaiyp_.
Zhu WJ; Department of Nursing, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Li M; Department of Breast Surgery, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Wu ZP; Department of Education, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Wang P; Department of Nursing, Taiyuan City Central Hospital, Taiyuan, 030009, Shanxi, China.
Wang XJ; Department of Nursing, Shanxi Bethune Hospital, Taiyuan, 030032, Shanxi, China.
Pokaż więcej
Źródło:
Journal of health, population, and nutrition [J Health Popul Nutr] 2024 Mar 07; Vol. 43 (1), pp. 40. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/therapy
Humans ; Blood Glucose ; Patient Compliance ; Hospitals
Czasopismo naukowe
Tytuł:
Predictive model for identifying mild cognitive impairment in patients with type 2 diabetes mellitus: A CHAID decision tree analysis.
Autorzy:
Maimaitituerxun R; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Chen W; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiang J; Department of Human Resources, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Xie Y; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Xiao F; Department of Toxicology, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Wu XY; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Chen L; Infection Control Center, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yang J; Department of Preventive Medicine, Changzhi Medical College, Changzhi, Shanxi, China.
Liu A; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Dai W; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2024 Mar; Vol. 14 (3), pp. e3456.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*
Diabetic Retinopathy*
Cognitive Dysfunction*/diagnosis
Cognitive Dysfunction*/etiology
Humans ; Middle Aged ; Aged ; Case-Control Studies ; Decision Trees
Czasopismo naukowe
Tytuł:
Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study.
Autorzy:
Fang Y; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Wang B; Department of Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Endocrinology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Pang B; Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zhou Z; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Xing Y; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Pang P; Department of Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Endocrinology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Zheng D; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China.; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Zhang G; The Community Health Service Center of Hangzhou Road Street in Tianjin Binhai New Area, Tianjin, China.
Yang B; Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Liqizhuang Street, Xiqing District, Tianjin, 300380, China. .; Department of Nephrology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3211. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/urine
Humans ; C-Reactive Protein/analysis ; Chemokine CCL2/urine ; Cross-Sectional Studies ; Lymphocytes/chemistry ; Neutrophils/chemistry ; Retrospective Studies ; ROC Curve
Czasopismo naukowe
Tytuł:
Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.
Autorzy:
Masuda T; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Katakami N; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Watanabe H; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Taya N; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Miyashita K; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Takahara M; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Kato K; Diabetes Center, NHO Osaka National Hospital, Osaka, Japan.
Kuroda A; Diabetes Therapeutics and Research Center, Institute of Advance Medical Sciences, Tokushima University, Tokushima, Japan.
Matsuhisa M; Diabetes Therapeutics and Research Center, Institute of Advance Medical Sciences, Tokushima University, Tokushima, Japan.
Shimomura I; Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
Journal of diabetes [J Diabetes] 2024 Feb; Vol. 16 (2), pp. e13486. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 2*
Diabetes Complications*/complications
Diabetic Nephropathies*/complications
Humans ; Adolescent ; Young Adult ; Adult ; Glycated Hemoglobin ; Carotid Intima-Media Thickness ; Ankle Brachial Index/adverse effects ; Glycemic Control/adverse effects ; Glycated Serum Albumin ; Japan ; Pulse Wave Analysis/adverse effects ; Cholesterol ; Risk Factors
Czasopismo naukowe
Tytuł:
Association between ELMO1 gene polymorphisms and diabetic kidney disease: A systematic review and meta-analysis.
Autorzy:
Azarboo A; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hosseinkhani S; Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ghaseminejad-Raeini A; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Aazami H; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadi SM; Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Zeidi S; Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Razi F; Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Bandarian F; Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 26; Vol. 19 (1), pp. e0295607. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/complications
Diabetes Mellitus, Type 2*/complications
Renal Insufficiency, Chronic*/complications
Humans ; Genetic Predisposition to Disease ; Polymorphism, Genetic ; Adaptor Proteins, Signal Transducing/genetics
Czasopismo naukowe
Tytuł:
Diabetic Kidney Disease Without Albuminuria: A New Entity in Diabetic Nephropathy.
Autorzy:
Ahmadi N
Amouzegar A; Firoozgar Clinical Research Development Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Iranian journal of kidney diseases [Iran J Kidney Dis] 2024 Jan; Vol. 1 (1), pp. 1-8.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/drug therapy
Diabetes Mellitus, Type 2*/complications
Humans ; Female ; Male ; Albuminuria/etiology ; Kidney Function Tests ; Risk Factors ; Glomerular Filtration Rate
Czasopismo naukowe
Tytuł:
Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy.
Autorzy:
Liu H; Department of Neurology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Tan S; Department of Neurology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Ma Z; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Gao Q; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yang W; Department of Neurology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Jan; Vol. 15 (1), pp. 106-112. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Neuropathies*/etiology
Diabetic Neuropathies*/complications
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/complications
Humans ; Early Diagnosis ; Neural Conduction/physiology
Czasopismo naukowe
Tytuł:
Gallic acid improves the metformin effects on diabetic kidney disease in mice.
Autorzy:
Hong Y; Department of Nephrology, Jiangnan University Medical Center (JUMC), Wuxi, China.; Department of Nephrology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Wang J; Department of Nephrology, Jiangnan University Medical Center (JUMC), Wuxi, China.; Department of Nephrology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Sun W; Department of Nephrology, Jiangnan University Medical Center (JUMC), Wuxi, China.; Department of Nephrology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Zhang L; Department of Nephrology, Jiangnan University Medical Center (JUMC), Wuxi, China.; Department of Nephrology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Xu X; Department of Nephrology, Jiangnan University Medical Center (JUMC), Wuxi, China.; Department of Nephrology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Zhang K; Department of Nephrology, Jiangnan University Medical Center (JUMC), Wuxi, China.; Department of Nephrology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2023 Dec; Vol. 45 (1), pp. 2183726. Date of Electronic Publication: 2023 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/etiology
Metformin*/pharmacology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Experimental*/complications
Diabetes Mellitus, Experimental*/drug therapy
Animals ; Mice ; Gallic Acid/pharmacology ; Gallic Acid/therapeutic use
Czasopismo naukowe
Tytuł:
Association between CNR1 gene polymorphisms and susceptibility to diabetic nephropathy in Iraqi patients with T2DM.
Autorzy:
Aljorani RH; Department of Clinical Laboratory Sciences, Faculty of Pharmacy, Al-Rafidain University College, Baghdad, Iraq.
Saleh ES; Department of Clinical Laboratory Sciences, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
Al Mohammadawi KG; Specialized Center for Endocrinology and Diabetes, Baghdad, Iraq.
Pokaż więcej
Źródło:
Journal of medicine and life [J Med Life] 2023 Nov; Vol. 16 (11), pp. 1663-1669.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/genetics
Diabetes Mellitus, Type 2*/epidemiology
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/epidemiology
Humans ; Gene Frequency/genetics ; Cross-Sectional Studies ; Iraq ; Genetic Predisposition to Disease/genetics ; Polymorphism, Genetic ; Genotype ; Polymorphism, Single Nucleotide/genetics ; Case-Control Studies ; Receptor, Cannabinoid, CB1/genetics
Czasopismo naukowe
Tytuł:
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
Autorzy:
Shimizu M; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Furuichi K; Department of Nephrology, Kanazawa Medical University, Uchinada, Japan.
Toyama T; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Yamanouchi M; Nephrology Center, Toranomon Hospital, Tokyo, Japan.
Hoshino J; Nephrology Center, Toranomon Hospital, Tokyo, Japan.; Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
Kitajima S; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Hara A; Department of Hygiene and Public Health, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Iwata Y; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Sakai N; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Yuzawa Y; Fujita Health University, Toyoake, Japan.
Kitamura H; Department of Pathology, National Hospital Organization Chiba-Higashi National Hospital, Chiba, Japan.
Sato H; JR Sendai Hospital, Sendai, Japan.
Shibagaki Y; Division of Nephrology, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki, Japan.
Suzuki Y; Division of Clinical Nephrology and Rheumatology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Uesugi N; Department of Pathology, Fukuoka University, Fukuoka, Japan.
Ueda Y; Department of Pathology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Kohagura K; Dialysis Unit, University of the Ryukyus Hospital, Nakagami-gun, Japan.
Samejima K; Department of Nephrology, Nara Medical University, Kashihara, Japan.
Tsuruya K; Department of Nephrology, Nara Medical University, Kashihara, Japan.
Nishi S; Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine School of Medicine, Kobe, Japan.
Nishino T; Department of Nephrology, Nagasaki University Hospital, Nagasaki, Japan.
Makino H; Okayama University, Okayama, Japan.
Matsuo S; Nagoya University, Nagoya, Japan.
Ubara Y; Nephrology Center, Toranomon Hospital, Tokyo, Japan.
Yokoyama H; Department of Nephrology, Kanazawa Medical University, Uchinada, Japan.
Wada T; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Pokaż więcej
Corporate Authors:
Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2023 Nov; Vol. 14 (11), pp. 1268-1278. Date of Electronic Publication: 2023 Jul 22.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/pathology
Diabetic Nephropathies*/epidemiology
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/pathology
Humans ; Biopsy ; Cohort Studies ; Disease Progression ; Kidney ; Proteinuria/complications ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Impact of metformin on cardiovascular and kidney outcome based on kidney function status in type 2 diabetic patients: a multicentric, retrospective cohort study.
Autorzy:
Yi Y; Department of Internal Medicine, Dankook University College of Medicine, Cheonan-si, Republic of Korea.
Kwon EJ; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Yun G; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Park S; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Jeong JC; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Na KY; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Chin HJ; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Yoo S; Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Kim S; Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Oh TJ; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Kim S; Division of Nephology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea. .; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. .; Center for Artificial Intelligence in Healthcare, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 24; Vol. 14 (1), pp. 2081. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Metformin*/therapeutic use
Diabetic Nephropathies*/drug therapy
Myristica*
Renal Insufficiency, Chronic*
Humans ; Retrospective Studies ; Kidney
Czasopismo naukowe
Tytuł:
Is eGFR Slope a Novel Predictor of Chronic Complications of Type 2 Diabetes Mellitus? A Systematic Review and Meta-Analysis.
Autorzy:
Sartore G; Department of Medicine-DIMED, University of Padua, Padova, Italy.
Ragazzi E; University of Padua, Padova, Italy.
Deppieri E; Department of Medicine-DIMED, University of Padua, Padova, Italy.
Lapolla A; Department of Medicine-DIMED, University of Padua, Padova, Italy.
Pokaż więcej
Źródło:
Journal of diabetes research [J Diabetes Res] 2024 Jan 17; Vol. 2024, pp. 8859678. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetic Nephropathies*
Kidney Failure, Chronic*/complications
Humans ; Data Collection ; Glycemic Control
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies